Bispecific monoclonal antibody
Bispecific monoclonal antibody (BsMAb) refers to an artificial protein that can simultaneously bind to two different types of antigen. BsMAbs are engineered to engage multiple targets at once, which can enhance their therapeutic effect compared to traditional monoclonal antibodies.
History[edit | edit source]
The concept of bispecific monoclonal antibodies was first introduced in the 1980s. The initial methods of production were complex and yielded low amounts of BsMAbs. However, with the advent of modern genetic engineering techniques, the production of BsMAbs has become more efficient and reliable.
Structure and Function[edit | edit source]
BsMAbs are composed of two different antibody fragments fused together. Each fragment is specific to a different antigen, allowing the BsMAb to bind to two different targets simultaneously. This dual targeting capability can enhance the therapeutic effect of the antibody, as it can engage multiple disease-related targets at once.
Therapeutic Applications[edit | edit source]
BsMAbs have a wide range of therapeutic applications, particularly in the field of oncology. They can be used to direct immune cells towards cancer cells, enhance the delivery of drugs to tumor sites, and block multiple signaling pathways that contribute to cancer progression. BsMAbs are also being explored for their potential in treating autoimmune diseases and infectious diseases.
Challenges and Future Directions[edit | edit source]
Despite their potential, the development and use of BsMAbs face several challenges. These include the complexity of their design and production, potential for increased toxicity due to dual targeting, and the need for further research to fully understand their mechanisms of action. However, ongoing advancements in antibody engineering and our understanding of disease biology continue to drive the development of more effective and safer BsMAbs.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD